BM
AGIO icon

Bridger Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bridger Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-220,099
Closed -$13.5M – 42
2014
Q3 		$13.5M Buy
220,099
+36,399
+20% +$1.57M 0.92% 35
2014
Q2 		$8.42M Buy
+183,700
New +$7.49M 0.59% 33

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

Bridger Management's AGIO Position: Q4 2014 in Review

Bridger Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2014, closing a stake of 220,099 shares — an estimated $13.5M sold.

Bridger Management first reported a position in AGIO in Q2 2014 and held it in 2 quarters. The position peaked at $13.5M in Q3 2014. 142 funds tracked by Wall St. Rank hold AGIO as of Q4 2014.

  • Bridger Management reported no remaining Agios Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Bridger Management sold 220,099 Agios Pharmaceuticals shares in Q4 2014, an estimated $13.5M.
  • Bridger Management first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Bridger Management's Agios Pharmaceuticals position peaked at $13.5M in Q3 2014.
  • 142 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2014.

Based on Bridger Management's 13F filing for Q4 2014, filed 17 Feb 2015.